Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Dow
Merck
AstraZeneca
Harvard Business School

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,511,581

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 8,511,581
Title:Fluid droplet production apparatus and method
Abstract: A fluid dispersion device comprises a substrate having an outer section and an inner section, said inner section of the substrate having an aperture, a dispersion element positioned at said aperture of said substrate, and an actuator arranged to coaxially surround said aperture of said substrate, wherein the outer edge of said inner section of said substrate is coupled to said outer section of said substrate by a plurality of resilient members.
Inventor(s): Urich; Markus (Munich, DE), Hyde; Samuel Charles William (Cambridge, GB), Pollock; Neil (Royston, GB), Sant; Andrew Jonathan (Cambridge, GB)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:13/042,980
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 8,511,581

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,511,581

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
02016972Aug 2, 2002

International Family Members for US Patent 8,511,581

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 463304   Start Trial
Germany 60235883   Start Trial
European Patent Office 1386672   Start Trial
World Intellectual Property Organization (WIPO) 2004014569   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Johnson and Johnson
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.